Press Releases

Advanced Search
  • Mar 28, 2017
    Biostage to present in the 3D Printing and BioEngineering panel on Thursday, March 30 at 2:30 PM ET

    Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...

  • Mar 16, 2017
    - Dr. La Francesca responsible for leading scientific and clinical advancement of Company's lead program, Cellspan esophageal implants, into human clinical trials before the end of 2017

    Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...

  • Mar 9, 2017
    - 2016 marked by establishing a strong foundation on operational, clinical and regulatory fronts in anticipation of a transformational year ahead

    Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...

  • Mar 2, 2017
    Conference Call with Live Audio Webcast on Thursday, March 9th at 9:00 AM ET

    Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...

  • Feb 16, 2017

    Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...

Show 5102550100 per page

print email rss